|
Hallucinogens (1) | HAND (7) | Haplorhini (2) |
Haplotypes (4) | Haptoglobins (1) | HCV (2) |
HCVcc (1) | HCVpp (1) | Headache (1) |
Health communication (1) | Health decision making (1) | Health disparities (2) |
Health Knowledge, Attitudes, Practice (1) | Health Literacy (1) | Health media (1) |
Health outcomes (1) | Health Services Needs and Demand (1) | Health Services Research (1) |
Health Status Disparities (1) | Health Surveys (2) | Healthy Aging (1) |
Healthy Lifestyle (1) | Hearing Aids (1) | Hearing Loss, Sensorineural (1) |
Heat (1) | HEK293 Cells (2) | Hela Cells (2) |
Heme Oxygenase-1 (3) | Hepacivirus (8) | Heparin (1) |
Hepatic dysfunction (1) | Hepatitis A Virus Cellular Receptor 1 (1) | Hepatitis A Virus Cellular Receptor 2 (1) |
Hepatitis B (1) | Hepatitis B Antibodies (1) | Hepatitis C (12) |
Hepatitis C Antibodies (2) | Hepatitis C, Chronic (1) | Hereditary Sensory and Autonomic Neuropathies (1) |
Heritable (1) | heroin (1) | Heroin Dependence (2) |
Herpesviridae Infections (1) | Herpesvirus 8 (3) | Heterocyclic Compounds, 3-Ring (1) |
Heterozygote (1) | High-Throughput Nucleotide Sequencing (1) | Highly Active (18) |
highly active antiretroviral therapy (HAART) (1) | Hippocampus (8) | Hispanic Americans (7) |
Hispanics (1) | Histidine (1) | Histocompatibility Antigens Class I (2) |
Histocompatibility Antigens Class II (1) | Histocompatibility Testing (1) | Histocytochemistry (2) |
History, 19th Century (1) | History, 20th Century (1) | History, 21st Century (1) |
HIV (55) | HIV Antibodies (1) | HIV associated neurocognitive disorders (1) |
HIV Co (1) | HIV Core Protein p24 (7) | HIV dementia (3) |
HIV encephalatis (HIVE) (1) | HIV encephalitis (1) | HIV Envelope Protein gp120 (18) |
HIV Envelope Protein gp160 (2) | HIV Envelope Protein gp41 (2) | HIV Fusion Inhibitors (1) |
HIV infection (1) | HIV Infections (257) | HIV Long Terminal Repeat (2) |
HIV Long-Term Survivors (1) | HIV neuropathogenesis (1) | HIV Protease (1) |
HIV Protease Inhibitors (4) | HIV Reverse Transcriptase (2) | HIV RNA (1) |
HIV Seronegativity (3) | HIV Seropositivity (11) | HIV-1 (105) |
HIV-1 gp120 (1) | HIV-1 lymphoma (1) | HIV-1 tat (1) |
HIV-1-associated dementia (1) | HIV-1-associated dementia. (1) | HIV-associaed neurocognitive disorder (HAND) (1) |
HIV-associated dementia (3) | HIV-associated neurocognitive disorder (5) | HIV-associated neurocognitive disorders (6) |
HIV-dementia (1) | HIV/AIDS (1) | HIVE (3) |
HLA Antigens (3) | HLA-A Antigens (1) | HLA-B Antigens (1) |
HLA-C Antigens (1) | HLA-DR Antigens (1) | HMGB1 Protein (3) |
HN Protein (1) | Homocysteine (1) | Homosexuality (1) |
Homosexuality, Male (1) | Host-Pathogen Interactions (3) | hpTau (1) |
Hu (1) | Huma (1) | Human (10) |
Human Immunodeficiency Virus (10) | Human Immunodeficiency Virus Proteins (4) | human immunodeficiency virus type 1 (1) |
Human neuron (1) | human postmortem brain (1) | Humans (374) |
Huntington Disease (1) | HVA (1) | Hybridization (1) |
Hydrogen-Ion Concentration (2) | Hydrolysis (1) | Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) |
Hyperalgesia (1) | Hyperglycemia (1) | Hyperinsulinism (1) |
Hyperlipidemias (1) | Hyperoxaluria (1) | Hypertrophy (1) |
Hypesthesia (1) | Hypothalamus (3) | Hypoxia-Inducible Factor 1, alpha Subunit (1) |